These reports provide both direct and indirect evidence for HDAC isoforms playing multiple roles in DNA damage response networks, and that HDAC inhibitors are capable of sensitizing cancer cells to killing by ionizing radiation. This evidence concerns the gene HDAC9 and cancer.